FDA Reopens Comment Period for Botanical Drug Products Draft Guidance

Summary

The FDA is extending the comment period for its draft guidance on botanical drug products until March 15, 2001, in response to a request for an extension, and provides guidance on when botanical drug products can be marketed over-the-counter or require FDA approval.